HIGHLIGHTS
- who: Manuel J. Rial from the Departmente for Health Research, Madrid, Spain have published the Article: Inflammatory Remission in T2 Severe Asthma, in the Journal: (JOURNAL)
- future: Future research should focus on at least two aspects determining true remission from a histological point of view and performing more thorough analyses of the biological pathways to explore the triggers that cause this phenomenon. Research into predictors of sustained well-controlled conditions after discontinuation of biologics is required to identify patients who are suitable candidates for biologics interruption.
SUMMARY
According to Menzies-Gow . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.